Device Trial Radar · NCT04660396
Monitoring Outpatient Blood VolumE in Heart Failure
Last checked: Nov 20, 2026Latest source record: Sep 29, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
15
Actual
Start
Sep 16, 2021
Primary completion
Jul 15, 2022
Study completion Jul 30, 2022
Sponsor
- Lead sponsor
- Daxor CorporationNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Geisinger Clinic
- First posted
- Dec 9, 2020
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In patients discharged following heart failure treatment, the consistency of blood volume status and components over time is unknown. The primary objective is to describe the rate of change, if any, of the plasma volume and red blood cell volume following hospitalization and discharge of patients with heart failure.
Conditions
- Heart Failure
Interventions
BVA-100Device
The BVA-100 is a software package designed to calculate human blood volume using the method of tracer dilution. It uses tagged serum albumin (a commonly used tag is 131I, resulting in "131I -HSA"). Data inputs to the software come from the measured characteristics of subject blood samples (hematocrit and tracer concentration) and tracer calibration standards. The package also calculates the subject expected (or ideal) blood volume from physical parameters. Hyper- or hypovolemia, associated red blood cell volumes, and transudation rate are reported, with statistics showing the quality of the results. The subject blood samples and calibration standards are measured in a gamma counter, whose output is automatically, or manually, input to this calculation program.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Quantify volume shifts in post discharge heart failure patientsTime frame: 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Geisinger
Danville, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.